tiprankstipranks
Trending News
More News >
Imugene (IUGNF)
OTHER OTC:IUGNF
US Market

Imugene (IUGNF) Stock Forecast & Price Target

Compare
39 Followers
See the Price Targets and Ratings of:

IUGNF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Imugene
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IUGNF Stock 12 Month Forecast

There Are No Analyst Ratings for IUGNF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IUGNF Financial Forecast

IUGNF Earnings Forecast

Next quarter’s earnings estimate for IUGNF is -$0.24 with a range of -$0.24 to -$0.24. The previous quarter’s EPS was -$0.07. IUGNF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year IUGNF has Performed in-line its overall industry.
Next quarter’s earnings estimate for IUGNF is -$0.24 with a range of -$0.24 to -$0.24. The previous quarter’s EPS was -$0.07. IUGNF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year IUGNF has Performed in-line its overall industry.
No data currently available

IUGNF Sales Forecast

Next quarter’s sales forecast for IUGNF is $1.41M with a range of $1.41M to $1.41M. The previous quarter’s sales results were $0.00. IUGNF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year IUGNF has Performed in-line its overall industry.
Next quarter’s sales forecast for IUGNF is $1.41M with a range of $1.41M to $1.41M. The previous quarter’s sales results were $0.00. IUGNF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year IUGNF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bell Potter Analyst forecast on IUGNF
Bell Potter
Bell Potter
$0.58
Buy
221.54%
Upside
Reiterated
10/15/25
Bell Potter Sticks to Its Buy Rating for Imugene (IUGNF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bell Potter Analyst forecast on IUGNF
Bell Potter
Bell Potter
$0.58
Buy
221.54%
Upside
Reiterated
10/15/25
Bell Potter Sticks to Its Buy Rating for Imugene (IUGNF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Imugene

3 Months
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-27.90%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -27.90% per trade.
1 Year
John HesterBell Potter
Success Rate
0/4 ratings generated profit
0%
Average Return
-47.27%
a rating ―
Copying John Hester's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.27% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-64.30%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -64.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IUGNF Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
1
1
1
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
0
0
In the current month, IUGNF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IUGNF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

IUGNF Stock Forecast FAQ

What is IUGNF’s average 12-month price target, according to analysts?
Currently, no data Available
What is IUGNF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IUGNF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IUGNF a Buy, Sell or Hold?
      Currently, no data Available
      What is Imugene’s price target?
      Currently, no data Available
      What do analysts say about Imugene?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IUGNF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.